Literature DB >> 11719160

Effects of epinephrine in a pig model of hypothermic cardiac arrest and closed-chest cardiopulmonary resuscitation combined with active rewarming.

E Kornberger1, K H Lindner, V D Mayr, B Schwarz, K S Rackwitz, V Wenzel, A C Krismer, P Mair.   

Abstract

OBJECTIVE: The aim of the current study was to assess the effects of epinephrine in a pig model of hypothermic cardiac arrest followed by closed-chest cardiopulmonary resuscitation combined with active rewarming, simulating the clinical management of an arrested hypothermic patient in a hospital without cardiopulmonary bypass facilities.
DESIGN: Prospective, randomized animal study.
SETTING: University research laboratory.
SUBJECTS: Twelve 12- to 16-week-old domestic pigs.
INTERVENTIONS: Pigs were surface cooled to a body core temperature of 28 degrees C. After 4 min of untreated cardiac arrest, manual closed-chest CPR and thoracic lavage with 40 degrees C warmed fluid were started. After 3 min of external chest compression animals were randomly assigned to receive epinephrine (45, 45 and 200 microg/kg) or saline placebo in 5-min intervals.
MEASUREMENTS AND MAIN RESULTS: Coronary perfusion pressure was about 15 mmHg in placebo group pigs. Coronary perfusion pressure was significantly higher after epinephrine, but restoration of spontaneous circulation was not more frequent (one of six epinephrine versus three of six saline placebo pigs, P=0.34). After 45 microg/kg epinephrine the arterial PO(2) was significantly lower when compared to the saline placebo. The third 200 microg/kg epinephrine dose resulted in a significantly enhanced mixed venous hypercarbic acidosis.
CONCLUSIONS: After a short 4-min period of hypothermic cardiac arrest, epinephrine may not be necessary to maintain coronary perfusion pressure around the threshold usually correlating with successful defibrillation, even during prolonged closed-chest CPR combined with active rewarming. The enhanced mixed venous hypercarbic acidosis in epinephrine-treated animals may support the argument against repeated or high dose epinephrine administration during hypothermic CPR.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11719160     DOI: 10.1016/s0300-9572(01)00353-7

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   5.262


  7 in total

Review 1.  [Therapeutic hypothermia after cardiac arrest].

Authors:  E Popp; F Sterz; B W Böttiger
Journal:  Anaesthesist       Date:  2005-02       Impact factor: 1.041

Review 2.  [Avalanche emergencies. Review of the current situation].

Authors:  P Paal; W Beikircher; H Brugger
Journal:  Anaesthesist       Date:  2006-03       Impact factor: 1.041

Review 3.  Drug administration in animal studies of cardiac arrest does not reflect human clinical experience.

Authors:  Joshua C Reynolds; Jon C Rittenberger; James J Menegazzi
Journal:  Resuscitation       Date:  2007-03-13       Impact factor: 5.262

4.  The physiologic responses to epinephrine during cooling and after rewarming in vivo.

Authors:  Torkjel Tveita; Gary C Sieck
Journal:  Crit Care       Date:  2011-09-23       Impact factor: 9.097

Review 5.  [Cardiac arrest under special circumstances].

Authors:  Carsten Lott; Anatolij Truhlář; Anette Alfonzo; Alessandro Barelli; Violeta González-Salvado; Jochen Hinkelbein; Jerry P Nolan; Peter Paal; Gavin D Perkins; Karl-Christian Thies; Joyce Yeung; David A Zideman; Jasmeet Soar
Journal:  Notf Rett Med       Date:  2021-06-10       Impact factor: 0.826

6.  The use of prefilled adrenaline syringes improves cardiopulmonary resuscitation quality-high-fidelity simulator-based study.

Authors:  Radosław Zalewski; Mateusz Puślecki; Tomasz Kłosiewicz; Maciej Sip; Bartłomiej Perek
Journal:  J Thorac Dis       Date:  2020-05       Impact factor: 3.005

7.  Study of the Effects of 3 h of Continuous Cardiopulmonary Resuscitation at 27°C on Global Oxygen Transport and Organ Blood Flow.

Authors:  Jan Harald Nilsen; Sergei Valkov; Rizwan Mohyuddin; Torstein Schanche; Timofei V Kondratiev; Torvind Naesheim; Gary C Sieck; Torkjel Tveita
Journal:  Front Physiol       Date:  2020-04-16       Impact factor: 4.566

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.